Research Analysts’ Updated EPS Estimates for February 11th (ARVN, BIIB, CVS, CXW, DDOG, LQDT, SHOP, VYGR, Z)

Research Analysts’ updated eps estimates for Tuesday, February 11th:

Arvinas (NASDAQ:ARVN) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $57.00 price target on the stock.

Biogen (NASDAQ:BIIB) had its target price cut by Bank Of America (Bofa) from $178.00 to $163.00. The firm currently has a neutral rating on the stock.

CVS Health (NYSE:CVS) had its price target lowered by UBS Group AG from $62.00 to $59.00. They currently have a neutral rating on the stock.

CVS Health (NYSE:CVS) had its target price boosted by Wolfe Research from 67.00 to 70.00. Wolfe Research currently has an overweight rating on the stock.

CVS Health (NYSE:CVS) had its price target raised by Leerink Partners from $51.00 to $55.00. They currently have a market perform rating on the stock.

CoreCivic (NYSE:CXW) had its outperform rating reiterated by analysts at Wedbush. They currently have a $30.00 price target on the stock.

Datadog (NASDAQ:DDOG) had its outperform rating reiterated by analysts at Macquarie. Macquarie currently has a $200.00 target price on the stock.

Liquidity Services (NASDAQ:LQDT) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $40.00 price target on the stock.

Shopify (NYSE:SHOP) (TSE:SHOP) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $125.00 price target on the stock.

Voyager Therapeutics (NASDAQ:VYGR) had its outperform rating reiterated by analysts at Wedbush. They currently have a $9.00 price target on the stock, down from their previous price target of $11.00.

Zillow Group (NASDAQ:Z) had its target price raised by Deutsche Bank Aktiengesellschaft from $90.00 to $95.00. The firm currently has a buy rating on the stock.